B. Metzler seel. Sohn & Co. Holding AG Takes Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 16,612 shares of the pharmacy operator’s stock, valued at approximately $149,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Redwood Investment Management LLC boosted its holdings in shares of Walgreens Boots Alliance by 0.9% in the first quarter. Redwood Investment Management LLC now owns 99,661 shares of the pharmacy operator’s stock valued at $2,162,000 after acquiring an additional 850 shares in the last quarter. Inlet Private Wealth LLC boosted its holdings in Walgreens Boots Alliance by 1.9% during the second quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock worth $578,000 after buying an additional 900 shares in the last quarter. Capital Investment Counsel Inc boosted its holdings in Walgreens Boots Alliance by 6.6% during the second quarter. Capital Investment Counsel Inc now owns 15,340 shares of the pharmacy operator’s stock worth $186,000 after buying an additional 950 shares in the last quarter. Continuum Advisory LLC boosted its holdings in Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 1,020 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in Walgreens Boots Alliance by 1.6% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 65,690 shares of the pharmacy operator’s stock worth $795,000 after buying an additional 1,038 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

WBA has been the subject of a number of research reports. Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. JPMorgan Chase & Co. reduced their price target on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Bank of America reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. TD Cowen reduced their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Finally, Barclays upped their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $12.88.

Walgreens Boots Alliance Stock Up 4.6 %

WBA stock opened at $9.06 on Tuesday. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $27.05. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The company has a market cap of $7.83 billion, a price-to-earnings ratio of -0.91, a PEG ratio of 1.14 and a beta of 0.69. The company has a 50 day moving average of $9.14 and a two-hundred day moving average of $11.45.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.67 EPS. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.04%. Walgreens Boots Alliance’s dividend payout ratio is currently -9.99%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.